Select Medical (SEM) Projected to Post Quarterly Earnings on Thursday

Key Points

• Select Medical is set to announce its Q3 2025 earnings on October 30, 2025, with expected earnings of $0.17 per share and revenue forecast of $1.3298 billion.
• The company has provided a FY 2025 guidance of $1.090-1.19 EPS and reported a net margin of 2.37% with revenue up 4.5% compared to the same quarter last year.
• Shares of Select Medical have been trading up 3.3%, and various analysts have differing ratings for the stock, with a consensus rating of "Moderate Buy" and target price of $19.40.

Select Medical (NYSE:SEM - Get Free Report) is projected to announce its Q3 2025 results after the market closes on Thursday, October 30th. Analysts expect the company to announce earnings of $0.17 per share and revenue of $1.3298 billion for the quarter. Select Medical has set its FY 2025 guidance at 1.090-1.19 EPS.Individuals may review the information on the company's upcoming Q3 2025 earningreport for the latest details on the call scheduled for Friday, October 31, 2025 at 9:00 AM ET.

Select Medical (NYSE:SEM - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The health services provider reported $0.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.04. The firm had revenue of $1.34 billion during the quarter, compared to the consensus estimate of $1.35 billion. Select Medical had a net margin of 2.37% and a return on equity of 8.87%. The business's revenue for the quarter was up 4.5% compared to the same quarter last year. During the same period last year, the business posted $0.60 earnings per share. On average, analysts expect Select Medical to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Select Medical Trading Up 3.3%

Shares of SEM stock opened at $14.27 on Thursday. The firm has a 50 day moving average price of $12.99 and a two-hundred day moving average price of $14.32. The company has a quick ratio of 1.15, a current ratio of 1.15 and a debt-to-equity ratio of 0.92. The company has a market capitalization of $1.77 billion, a PE ratio of 13.46, a price-to-earnings-growth ratio of 0.56 and a beta of 1.28. Select Medical has a 12-month low of $11.65 and a 12-month high of $40.98.

Select Medical Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 28th. Shareholders of record on Wednesday, August 13th were given a dividend of $0.0625 per share. The ex-dividend date was Wednesday, August 13th. This represents a $0.25 annualized dividend and a yield of 1.8%. Select Medical's dividend payout ratio (DPR) is 23.58%.

Analyst Ratings Changes

Several equities research analysts have issued reports on the stock. Bank of America cut their price objective on shares of Select Medical from $18.00 to $15.00 and set a "buy" rating for the company in a research report on Wednesday, September 10th. Royal Bank Of Canada raised their target price on shares of Select Medical from $16.00 to $20.00 and gave the stock an "outperform" rating in a report on Wednesday, October 8th. UBS Group reaffirmed a "neutral" rating and set a $14.00 target price (down from $15.00) on shares of Select Medical in a report on Monday, August 4th. Finally, Weiss Ratings reaffirmed a "sell (d+)" rating on shares of Select Medical in a report on Wednesday, October 8th. Four equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $19.40.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the company. State Street Corp increased its stake in Select Medical by 1.3% in the second quarter. State Street Corp now owns 4,253,793 shares of the health services provider's stock valued at $64,573,000 after acquiring an additional 55,686 shares during the last quarter. 8 Knots Management LLC bought a new position in Select Medical in the second quarter valued at approximately $26,568,000. Bank of America Corp DE increased its stake in Select Medical by 10.9% in the second quarter. Bank of America Corp DE now owns 1,618,662 shares of the health services provider's stock valued at $24,571,000 after acquiring an additional 158,768 shares during the last quarter. Goldman Sachs Group Inc. increased its stake in Select Medical by 25.3% in the first quarter. Goldman Sachs Group Inc. now owns 728,689 shares of the health services provider's stock valued at $12,169,000 after acquiring an additional 147,183 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its stake in Select Medical by 24.1% in the second quarter. JPMorgan Chase & Co. now owns 444,415 shares of the health services provider's stock valued at $6,746,000 after acquiring an additional 86,343 shares during the last quarter. 89.48% of the stock is owned by institutional investors.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.